These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28500995)

  • 1. Antibacterial activity and mechanism of action of the benzazole acrylonitrile-based compounds: In vitro, spectroscopic, and docking studies.
    AlNeyadi SS; Salem AA; Ghattas MA; Atatreh N; Abdou IM
    Eur J Med Chem; 2017 Aug; 136():270-282. PubMed ID: 28500995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting clinically-relevant metallo-β-lactamases: from high-throughput docking to broad-spectrum inhibitors.
    Brindisi M; Brogi S; Giovani S; Gemma S; Lamponi S; De Luca F; Novellino E; Campiani G; Docquier JD; Butini S
    J Enzyme Inhib Med Chem; 2016; 31(sup1):98-109. PubMed ID: 27121013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azolylthioacetamides as a potent scaffold for the development of metallo-β-lactamase inhibitors.
    Xiang Y; Chang YN; Ge Y; Kang JS; Zhang YL; Liu XL; Oelschlaeger P; Yang KW
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5225-5229. PubMed ID: 29122480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-guided optimization of 1H-imidazole-2-carboxylic acid derivatives affording potent VIM-Type metallo-β-lactamase inhibitors.
    Yan YH; Li W; Chen W; Li C; Zhu KR; Deng J; Dai QQ; Yang LL; Wang Z; Li GB
    Eur J Med Chem; 2022 Jan; 228():113965. PubMed ID: 34763944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioassay Guided Isolation and Docking Studies of a Potential β-Lactamase Inhibitor from
    Elfaky MA; El-Halawany AM; Koshak AE; Alshali KZ; El-Araby ME; Khayat MT; Abdallah HM
    Molecules; 2020 May; 25(11):. PubMed ID: 32486455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The assemblage of covalent and metal binding dual functional scaffold for cross-class metallo-β-lactamases inhibition.
    Chen C; Liu Y; Zhang YJ; Ge Y; Lei JE; Yang KW
    Future Med Chem; 2019 Sep; 11(18):2381-2394. PubMed ID: 31544522
    [No Abstract]   [Full Text] [Related]  

  • 7. NOTA analogue: A first dithiocarbamate inhibitor of metallo-β-lactamases.
    Zhang E; Wang MM; Huang SC; Xu SM; Cui DY; Bo YL; Bai PY; Hua YG; Xiao CL; Qin S
    Bioorg Med Chem Lett; 2018 Jan; 28(2):214-221. PubMed ID: 29248295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-(Sulfamoylbenzoyl)-L-proline Derivatives as Potential Non-β-lactam ESBL Inhibitors: Structure-Based Lead Identification, Medicinal Chemistry and Synergistic Antibacterial Activities.
    Liu X; Dong S; Ma Y; Xu H; Zhao H; Gao Q
    Med Chem; 2019; 15(2):196-206. PubMed ID: 30112996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and in vitro and biological evaluation of potent amino acid-derived thiol inhibitors of the metallo-β-lactamase IMP-1.
    Arjomandi OK; Hussein WM; Vella P; Yusof Y; Sidjabat HE; Schenk G; McGeary RP
    Eur J Med Chem; 2016 May; 114():318-27. PubMed ID: 27017264
    [TBL] [